Exposure to extremely low-frequency electromagnetic fields inhibits T-type calcium channels via AA/LTE4 signaling pathway  by Cui, Yujie et al.
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a  b  s  t  r  a  c  t
Extremely  low-frequency  electromagnetic  ﬁelds  (ELF-EMF)  causes  various  biological  effects  through
altering  intracellular  calcium  homeostasis.  The  role  of  high  voltage-gated  (HVA)  calcium  channels  in
ELF-EMF  induced  effects  has been  extensively  studied.  However,  the effect  of  ELF-EMF  on low-voltage-
gated  (LVA)  T-type  calcium  channels  has  not  been  reported.  In this  study,  we  test the  effect  of  ELF-EMF
(50  Hz)  on  human  T-type  calcium  channels  transfected  in  HEK293  cells.  Conversely  to its  stimulant  effects
on  HVA  channels,  ELF-EMF  exposure  inhibited  all T-type  (Cav3.1,  Cav3.2  and  Cav3.3)  channels.  Neither
the  protein  expression  nor  the  steady-state  activation  and  inactivation  kinetics  of  Cav3.2  channels  were
pen access under CC BY-NC-SA license.elds
-type calcium channels
he  cysteinyl leukotrienes
altered  by  ELF-EMF  (50  Hz,  0.2 mT)  exposure.  Exposure  to  ELF-EMF  increased  both  arachidonic  acid  (AA)
and  leukotriene  E4 (LTE4)  levels  in HEK293  cells.  CAY10502  and  bestatin,  which  block  the increase  of
AA  and  LTE4 respectively,  abrogated  the ELF-EMF  inhibitory  effect  on  Cav3.2  channels.  Exogenous  LTE4
mimicked  the  ELF-EMF  inhibition  of T-type  calcium  channels.  ELF-EMF  (50  Hz)  inhibits  native  T-type
calcium  channels  in primary  cultured  mouse  cortical  neurons  via  LTE4. We  conclude  that  50 Hz ELF-EMF
hanneinhibits  T-type  calcium  c
. Introduction
Exposure to Extremely low-frequency electromagnetic ﬁelds
ELF-EMF) causes various cellular and physiological effects (for
eviews, see references [1–3]). Calcium homeostasis has been the
ocus of biological effects of ELF-EMF, and compelling studies
how that calcium plays important roles in ELF-EMF induced var-
ous biological effects [4–10]. A number of studies suggested that
oltage-gated calcium channels (VGCCs) maybe one of the direct
argets of ELF-EMF (for review, see reference [11]). VGCCs include
igh-voltage-gated [Cav1 family (L-type), Cav2 family (P/Q-type,
-type and R-type)] and low-voltage-gated [Cav3 family (T-type)]
alcium channels [12].
Among  high-voltage-gated calcium channels, the role of L-
ype calcium channels in ELF-EMF (50/60 Hz) induced effects has
een well studied. The L-type calcium channel inhibitor nifedip-
ne inhibits ELF-EMF (60 Hz) induced neurite-like growth of rat
hromafﬁn cells, and BayK8644 (an agonist of L-type calcium
 This is an open-access article distributed under the terms of the Creative
ommons  Attribution-NonCommercial-ShareAlike License, which permits non-
ommercial use, distribution, and reproduction in any medium, provided the
riginal author and source are credited.
∗ Corresponding author at: School of Life Sciences and Institutes of Brain Science,
udan  University, 220 Handan Road, Shanghai 200433, China. Tel.: +86 21 65643924;
ax:  +86 21 55664711.
E-mail address: clhu@fudan.edu.cn (C. Hu).
143-4160      © 2013 The Authors. Published by Elsevier Ltd. All rights reserved.
ttp://dx.doi.org/10.1016/j.ceca.2013.11.002ls  through  AA/LTE4 signaling  pathway.
©  2013  The  Authors.  Published  by  Elsevier  Ltd.  All  rights  reserved.
channels) promotes ELF-EMF induced neurite-like growth in
chromafﬁn cells [13]. Through increasing L and N-type channel
expression, ELF-EMF(50 Hz) promotes proliferation of human neu-
roblastoma IMR32 and rat pituitary GH3 cell, and reduces IMR32
cell apoptosis induced by puromycin and H2O2 [14]. Nimodip-
ine, an L-type channel blocker, inhibits ELF-EMF (60 Hz) induced
thermal hyperalgesia in mice [15]. The L-type channel inhibitor
nifedipine prevents ELF-EMF (50 Hz) induced differentiation of
pituitary AtT20 D16V cells [16]. ELF-EMF (50 Hz) promotes neuro-
genesis both in vivo and in vitro through enhancing Cav1-channel
activity [17,18]. N-type calcium channels are also involved in ELF-
EMF  induced biological effects [14]. The literature above indicates
that ELF-EMF has a stimulant effect on high-voltage-gated calcium
channels.
Compared to high-voltage-gated calcium channels, low-
voltage-gated T-type calcium channels have unique electrophys-
iological features of activation at subthreshold voltages, slow
deactivation, fast inactivation, and tiny single-channel conductance
[12,19,20]. T-type calcium channels, consisting of Cav3.1, Cav3.2
and Cav3.3 subtypes, are widely expressed and play key roles in
various physiological and pathological functions such as neuronal
burst ﬁring, cardiac pacemaking, secretion of hormones, cardiac
hypertrophy, tumor proliferation and epilepsy [19,21,22]. So far,
the effect of exposure to ELF-EMF on T-type calcium channels has
remained unclear.
In  present study, we test whether ELF-EMF (50 Hz) has effect
on cloned human T-type calcium channel activity in HEK293 cells,
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nd on T-type calcium channels in primary cultured mouse corti-
al neurons. Surprisingly, our results showed that conversely to its
timulant effects on L-type calcium channels, ELF-EMF inhibited T-
ype channel currents. Our results provide the ﬁrst evidence that:
) exposure to ELF-EMF increases LTE4 release from HEK293 cells,
) Exogenous LTE4 inhibits T-type calcium channels, and 3) ELF-
MF  (50 Hz) exposure inhibits T-type calcium channel via AA/LTE4
ignaling pathway.
. Materials and methods
.1. Ethics statement
The study was carried out in strict accordance with the recom-
endations in the Guide for the Care and Use of Laboratory Animals
f the National Institutes of Health. The protocol was  approved by
he Committee on the Ethics of Animal Experiments of the Fudan
niversity. All surgery was performed under sodium pentobarbital
nesthesia, and all efforts were made to minimize suffering.
.2. Chemicals
Nordihydroguaiaretic acid (NDGA), ﬂufenamic acid (FA), 17-
ctadecynoic acid (ODYA), BAY9773 and Bestatin were purchased
rom Sigma–Aldrich (St. Louis, MO,  USA); Leukotriene E4 and
AY10502 were purchased from Cayman Chemical (Ann Arbor, MI,
SA).
.3. Cell culture and transfection
HEK293 (human embryonic kidney cells) cells were purchased
rom the cell bank of Chinese Academy of Sciences (Shanghai,
hina). Cells were cultured in Dulbecco’s modiﬁed Eagle’s medium
DMEM, GIBICO) supplemented with 10% fetal bovine serum, 1%
ntibiotic antimycotic solution (Gibco). Transient transfections
ith plasmids for human Cav3.1, Cav3.2 (kindly provided by Pro-
essor Paula Barrett [23]) and Cav3.3 (kindly provided by Professor
dward Perez-Reyes [24]) channels in pcDNA3 plasmids were per-
ormed using jetPRIME reagents (Polyplus-transfection) according
o the manufacturer’s instructions, and were used for patching or
ther biochemical tests 24 h after transfection.
Cortical neurons were derived from the cerebral neocortex of
5-day-old embryonic ICR mice as originally described [25]. Iso-
ated cells were then plated onto 35-mm-diameter Petri dishes
oated with poly-l-lysine (1 g/mL) at a density of 1 × 105 cells
er dish. The cultured cells were cultured in Dulbecco’s Modiﬁed
agle’s Medium (DMEM) supplemented with 10% fetal calf serum,
0% heat-inactivated horse serum and a 1% antibiotic–antimycotic
olution. All experiments were carried using cortical neurons at
–10 days in culture.
.4. Electrophysiology
Whole-cell currents in the HEK293 cells were recorded using
n Axopatch 200B or 700B ampliﬁer (Axon Instruments). The bath
olution contained (in mM)  143 TEACl, 10 CaCl2, 2 MgCl2, 10 HEPES,
0 glucose, pH 7.4 (adjusted with TEAOH). The internal solution
ontained (in mM)  125 CsCl, 10 HEPES, and 10 EGTA, 1 MgCl2, 1
aCl2, 5 Mg-ATP, 0.3 Tris-GTP (pH adjusted to 7.2 using CsOH). The
ipettes were created from capillary tubing (BRAND, Wertheim,
ermany) and had resistances of 4–6 M under these solution
onditions. All of the recordings were performed at room temper-
ture. Steady-state calcium channel activation was  determined by
ail currents using the following protocol. The cells were held at
90 mV and depolarized in 5-mV steps from −60 to +15 mV at 10-s
ntervals upon repolarization to −70 mV.  For steady-state channel 55 (2014) 48–58 49
inactivation, the cells were tested at −20 mV from a pre-pulse incre-
mented in 5 mV  (−85 mV  to −30 mV;  10 s) upon repolarization to
−70 mV.  The currents were sampled at 10 kHz and ﬁltered at 2 kHz,
and corrected online for leak and residual capacitance transients
using a P/4 protocol.
2.5. Intracellular AA assay
Intracellular AA levels in HEK 293 cells were measured as previ-
ously described [26]. Brieﬂy, HEK 293 cells were plated in 35-mm
dishes and grown to conﬂuence. Before test, the culture medium
was changed to 1 mL DMEM without serum, and cells were exposed
to ELF-EMF (50 Hz, 0.2 mT)  for 1 h. The medium was then removed,
and the cells were lysed using 0.45% NP40. The lysate was cen-
trifuged for 5 min  at 4 ◦C. The supernatant was  then collected for AA
assay using a direct human AA ELISA kit (R&B, Lianshuo Bio-Tech,
Shanghai, China) according to the manufacturer’s instructions.
2.6. LTE4 release assay
LTE4 levels in the culture media were measured using highly
sensitive enzyme-linked immunosorbent assay kits (R&B, Lianshuo
Bio-Tech, Shanghai, China) according to the manufacturer’s instruc-
tions. Brieﬂy, HEK 293 cells were plated in 35-mm dishes and grown
to conﬂuence. Before test, the culture medium was  changed to 1 mL
DMEM without serum and cells were exposed to ELF-EMF (50 Hz,
0.2 mT)  for various time (0.5 h, 1 h, 2 h, 3 h). The media were then
collected and centrifuged for 5 min  at 4 ◦C. The supernatant was
collected and assayed for levels of LTE4.
2.7. Western blot
Cell homogenates were prepared using HEPES-NP40 lysis buffer
(20 mM  HEPES, 150 mM NaCl, 0.5% NP-40, 10% glycerol, 2 mM  EDTA,
100 M Na3VO4, 50 M NaF, pH 7.5). The protein samples were
resolved using 10% SDS PAGE and transferred to polyvinyldiﬂuo-
ride (PVDF) membranes in a transfer buffer (25 mM Tris, 192 mM
glycine, 20% methanol, v/v) at 230 mA for 2 h. The PVDF membranes
were blocked with 10% nonfat dry milk in TBST (TBS containing
0.05% Tween 20) for 1 h at room temperature. The membranes were
incubated with the primary antibody in TBST with 5% BSA (bovine
serum albumin), overnight at 4 ◦C. The blot was washed 3 times
for 10 min  in TBST and incubated with a horseradish peroxidase-
conjugated secondary antibody (1/50,000) (KangChen Bio-tech) in
TBST with 5% nonfat dry milk for 1 h at room temperature. The
blots were developed using enhanced chemiluminescence (ECL)
reagents from Pierce and the ChemiDoc XRS+ imaging system from
Bio-Rad.
2.8. ELF-EMF exposure
The system used to generate electromagnetic ﬁelds was the
same as previous reported [26]. Brieﬂy, HEK293 cells were exposed
to a magnetic ﬁeld (50 Hz, 0.2 mT)  produced by a pair of Helmholtz
coils, which were powered by an AC generator system. The geome-
try of the system assured a uniform ﬁeld for cell exposure. An EMF
sensor connected to a digital multimeter was used to continuous
monitor the frequency and density of EMF. All ELF-EMF experi-
ments were done with a frequency of 50 Hz and a density of 0.2 mT.
Duration of ELF-EMF exposure, air and culture medium tempera-
tures were continuously monitored, and ELF-EMF (50 Hz, 0.2 mT)
did not change the temperature of the CO2 incubator (37 ◦C). Non-
EMF  control groups were placed in the same incubator in which the
conditions were the same as for the exposed groups but without
EMF.
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Fig. 1. Exposure to ELF-EMF (50 Hz, 0.2 mT)  inhibits Cav3.2 channels in HEK 293 cells. (A) Sample current traces were obtained from HEK293 cells expressed Cav3.2
channels inhibited by exposure to ELF-EMF for different time periods (from 0.5 h to 3 h). (B) Histogram plots of mean ± S.E.M. of ICa current density normalized by control
(n  = 45–60). *P < 0.05 compared to control using a one-way ANOVA test. (C) current–voltage (I–V) currents obtained from Cav3.2-transfected HEK293 cells with/without
exposure to ELF-EMF for 1 h (50 Hz, 0.2 mT). (D) I–V relationship curves generated by peak current density at each test voltage. Data were presented as means ± S.E.M. from
50  cells.
Fig. 2. ELF-EMF exposure did not alter the steady-state activation/inactivation properties and protein expression of Cav3.2. (A) The effect of ELF-EMF exposure for
1  h on the steady-state activation of Cav3.2. The current traces show the voltage-dependent Cav3.2 current activation curves in the absence (top) and presence (middle) of
ELF-EMF exposure; the normalized data points were ﬁtted using a Boltzmann equation (bottom). ELF-EMF did not alter the steady-state Cav3.2 activation. (B) The effect
of  ELF-EMF exposure on the steady-state activation of Cav3.2. The current traces show the voltage-dependent Cav3.2 current inactivation curves in the absence (top) and
presence  (middle) of ELF-EMF exposure; the normalized data points were ﬁtted using a Boltzmann equation (bottom). ELF-EMF did not change the steady-state Cav3.2
inactivation. (C) 1 h exposure to ELF-EMF did not alter the protein expression of Cav3.2 channels. A representative image (Upper) and the statistical analysis of Western blot
from  4 independent experiments (lower).
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Fig. 3. The ELF-EMF inhibition of Cav3.2 current is mediated by AA. (A) ELF-EMF exposure increased AA concentration in HEK293 cells in a time-dependent manner.
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LF-EMF on CaV3.2 channels. Currents were elicited by a depolarizing pulse to −35 
he  ELF-EMF induced inhibition of Cav3.2 channels. *P < 0.05 compared to the non E
.9. Data analysisThe data analysis was performed with Clampﬁt 10.3 (Axon
nstruments) and Origin 7.5 software (OriginLab). The statistical
ig. 4. The inhibition of Cav3.2 currents by ELF-EMF exposure is mediated by the l
ndoperoxide H synthase inhibitor), ODYA (cytochromes P450 inhibitor) and NDGA (lipox
EK293 cells. (B) Statistical analysis of the inhibitory effects of ELF-EMF exposure on Cav3
0uM  NDGA abrogated the EMF  inhibition of Cav3.2 channels. Both FA and 17-ODYA did n
o  non-EMF control using Students’ t-test. #P < 0.05 compared to the EMF-exposed groupe from 3 independent experiments. (C) CAY10502 blocked the inhibitory effect of
m holding at −90 mV. (D) Statistical analysis of the blocking effect of CAY10502 on
posed control. #P < 0.05 compared to the EMF-exposed group without CAY10502.
analysis consisted of unpaired or paired (depending on the circum-
stances) Student’s t tests. Values are given as the means ± S.E.M, and
n indicates the number of tested cells or independent test. P < 0.05
was deﬁned to be a statistically signiﬁcant difference between
ipoxygenase pathway. (A) Current traces show the effects of FA (prostaglandin
ygenase inhibitor) on ELF-EMF induced inhibition of Cav3.2 channels expressed in
.2 channels in the present or absent of FA(left), 17-ODYA (middle) and NDGA(right).
ot affect the ELF-EMF inhibition of Cav3.2 channels signiﬁcantly. *P < 0.05 compared
 without NDGA.
52 Y. Cui et al. / Cell Calcium 55 (2014) 48–58
Fig. 5. The ELF-EMF inhibition of Cav3.2 channels is mediated by LTE4. (A) The cysteinyl leukotriene receptor antagonist BAY9773 did not change the inhibitory effect
of  ELF-EMF on Cav3.2 channels. Representative current trances were elicited by a test pulse at −35 mV from holding at −90 mV (left). Statistical analysis of the effects of
BAY9773  on the ELF-EMF induced inhibition of Cav3.2 channels (right). (B) Bestatin, which blocks the conversion from LTD4 to LTE4, abrogated the ELF-EMF inhibition of
Cav3.2  channels. Currents show ELF-EMF effect on Cav3.2 currents in the presence of bestatin (left). Bar graph plots of means ± S.E.M. of normalized Cav3.2 current density
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roups. Multiple comparisons were analyzed using a one-way anal-
sis of variance (ANOVA) followed by the post hoc Tukey test.
. Results
.1. Extremely low-frequency electromagnetic ﬁelds (ELF-EMF)
nhibits Cav3.2 channel currents
Cav3.2 currents were elicited by a 40-ms depolarizing pulse
o −35 mV  from a holding potential of -90 mV  at 10 s intervals.
LF-EMF (50 Hz, 0.2 mT)  exposure inhibited Cav3.2 currents in a
ime-dependent manner (percent inhibition: 0.5 h EMF: 11 ± 2.1%,
 = 45; 1 h EMF: 31.1 ± 4.71%, n = 65; 2 h EMF: 4.3 ± 2.4%, n = 60;
 h EMF: 3.7 ± 2.3%, n = 52; Fig. 1A and B). The inhibitory effect
eached a maximum at about 1 h, so we used 1 h ELF-EMF
0.2 mT)  exposure for all of the following experiments. ELF-
MF decreased Cav3.2 channel currents at all voltages (Fig. 1C
nd D). The current–voltage (I–V) relationship was elicited by
 step protocol (holding at −90 mV,  depolarizing in 5-mV steps
rom −60 to +25 mV at 10-s intervals). We  tested whether
LF-EMF inhibited Cav3.2 channels through altering the steady-
tate activation and inactivation of Cav3.2 channel currents. As
hown in Fig. 2, exposure to ELF-EMF did not change either
he steady-state activation (control: V1/2 = −45.1 ± 0.6 mV,  n = 20;
MF: V1/2 = −45.3 ± 0.2 mV,  n = 20, P > 0.05, Fig. 2A) or inactivation
control: V1/2 = −65.1 ± 0.5 mV,  n = 20; EMF: V1/2 = −65.2 ± 0.4 mV,
 = 20, P > 0.05, Fig. 2B) kinetics of Cav3.2 channel currents. We
hen studied whether ELF-EMF exposure inhibited Cav3.2 currents
y changing protein expression. Western blot results showed that
 h exposure to ELF-EMF (0.2 mT)  did not altered Cav3.2 channel
xpression (EMF: 2.67 ± 3.91%, n = 4, P > 0.05 compared to control,
ig. 2C).roup without bestatin.
3.2. The ELF-EMF inhibition of Cav3.2 currents is abrogated by
blocking arachidonic acid (AA) increase
AA has been shown to inhibit Cav3.2 channels [27], and a recent
study reports that 50 Hz ELF-EMF increases intracellular AA con-
centration of rat cerebellar granule cells [26]. Therefore, we tested
whether the ELF-EMF inhibition of Cav3.2 channels was  medi-
ated via increasing AA. As shown in Fig. 3A, ELF-EMF exposure
increased AA concentration in HEK293 cells in a time depend-
ent manner (0.5 h: 8.0 ± 0.8%; 1 h: 17.9 ± 3.4%; 2 h: 3.3 ± 4.1%; 3 h:
1.7 ± 2.1%, n = 3). The phospholipase A2 inhibitor CAY10502, which
inhibits AA release from the phospholipid pools, abrogated ELF-
EMF  (1 h) induced AA increase (EMF: 17.9 ± 3.4%; EMF  + CAY10502:
3.6 ± 2.7%, P < 0.05, Fig. 3B) and the ELF-EMF inhibitory effect
of Cav3.2 channels (EMF: 35.7 ± 4.9%, n = 48; EMF  + CAY10502:
8.9 ± 5.4%, n = 48; P < 0.05, Fig. 3C and D), which indicated that
ELF-EMF exposure inhibited Cav3.2 channels through AA signaling
pathway. AA shifts the steady-state inactivation of Cav3.2 currents
[27], however, ELF-EMF exposure did not change either steady-
state voltage activation or inactivation of Cav3.2 currents (Fig. 2).
Therefore, we speculated that ELF-EMF might inhibit Cav3.2 chan-
nels by downstream metabolites of AA.
3.3. The ELF-EMF inhibition of Cav3.2 channels is mediated by
LTE4
AA has three major downstream signaling pathways which were
mediated by the prostaglandin endoperoxide H synthase (PGHS),
lipoxygenase (LOX) and cytochromes P450 respectively [28,29]. We
used FA, NDGA and ODYA to block the above three enzymes respec-
tively. FA, ODYA and NDGA per se had no effect on Cav3.2 channels
(Fig. 4). FA and ODYA did not alter the inhibitory effect of ELF-EMF
on Cav3.2 channels (EMF: 31.6 ± 4.2%, n = 36; EMF + FA: 28.2 ± 5.1%,
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Fig. 6. LTE4 replicates the inhibitory effect of ELF-EMF on Cav3.2 channels. (A) Representative current traces show the inhibitory effect of exogenous LTE4 on Cav3.2
channels (top left). The time course of the Cav3.2 current inhibition by 1 M LTE4 (bottom left). Statistical analysis of the effect of exogenous LTE4 on ICa. The data are
reported as the means ± S.E.M. from 7 cells (right). *P < 0.05 compared to control. (B) 1 M LTE4 did not alter the steady-state activation property of Cav3.2 currents (right).
Representative currents with/without LTE4 shown to the left. (C) 1 M LTE4 did not alter the steady-state inactivation kinetics of Cav3.2 currents (right). Representative
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P  < 0.05 compared to non-EMF control.
 = 36; EMF  + ODYA: 28.7 ± 4.5%, n = 34, P > 0.05, Fig. 4A and B).
owever, 10 M NDGA completely diminished the ELF-EMF inhi-
ition of Cav3.2 channels (EMF: 31.1 ± 3.1%, n = 38; EMF  + NDGA:
.4 ± 6.1%, n = 38, P < 0.05, Fig. 4A and B), which suggested that ELF-
MF  exposure inhibited Cav3.2 channels through LOX-mediated
ignaling pathway. Through LOX pathway, AA is converted to
eukotriene C4 (LTC4), leukotriene D4 (LTD4) and leukotriene E4
LTE4) ﬁnally by successive enzymatic conversions [30–32]. We
ext investigated which metabolite of AA inhibited Cav3.2 chan-
els.
So far, there are only two cysteinyl leukotriene receptors
CysLT1 and CysLT2) identiﬁed, which have high afﬁnity for
TC4 and LTD4 binding, but have little afﬁnity for LTE4 [33,34].ase in a time-dependent manner. The data are from 4 independent experiments.
BAY9773, a non-selective antagonist for both CysLT1 and CysLT2,
did not change the inhibitory effect of ELF-EMF on Cav3.2
channels (EMF: 31.6 ± 3.1%, n = 40; EMF  + BAY9773: 28.9 ± 3.3%,
n = 40, P > 0.05, Fig. 5A). Bestatin, which blocks the conversion
from LTD4 to LTE4, was used to test whether the ELF-EMF
inhibition of Cav3.2 channel currents was  mediated by LTE4. 5 M
bestatin totally abrogated the ELF-EMF inhibition of Cav3.2 chan-
nels (EMF: 31.8 ± 2.7%, n = 36; Emf  + bestatin: 6.02 ± 2.1%, n = 36,
P < 0.05, Fig. 5B). The above data demonstrated that ELF-EMF expo-
sure inhibited Cav3.2 channels via LTE4 instead of LTC4 and LTD4.
We next asked whether exogenous LTE4 could inhibit Cav3.2
channels, and whether ELF-EMF could increase LTE4 produc-
tion. As shown in Fig. 6, 1 m LTE4 inhibited Cav3.2 channels
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Fig. 7. ELF-EMF (50 Hz, 0.2 mT)  inhibits both Cav3.1 and Cav3.3 channels. (A) Effect of exposure to ELF-EMF (1 h) on the Cav3.1 channels expressed in HEK293 cells. Sample
current  traces shown ELF-EMF inhibition of Cav3.1 current (left); Statistical analysis of the effect of ELF-EMF exposure on Cav3.1 channels (right). The data are reported as
means ± S.E.M. from 48 cells. *P < 0.05 compared to non-EMF control. (B) Exposure to ELF-EMF did not alter the steady-state activation (left) and inactivation (right) curves
of  Cav3.1 currents. (C) Effect of ELF-EMF exposure (1 h) on Cav3.3 channels. Sample current traces shown ELF-EMF inhibition of Cav3.3 current (left); Statistical analysis of
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nhe  effect of ELF-EMF exposure on Cav3.3 channels (right). The data are reported a
LF-EMF  did not alter the steady-state activation (left) and inactivation (right) curv
y 46.4 ± 3%, and LE4 did not altered the steady-state activation
control: V1/2 = −44.9 ± 0.3 mV,  n = 6; LTE4: V1/2 = −45.1 ± 0.3 mV,
 = 6, Fig. 6B) and inactivation (control: V1/2 = −65.2 ± 0.3 mV,  n = 7;
TE4: V1/2 = −65.6 ± 0.5 mV,  n = 7, P > 0.05, Fig. 6C) properties of
av3.2 currents. The inhibitory effect of LTE4 on Ica began quickly
nd reached a maximum effect within 2 min. The inhibition was
eversible within 2–3 min  (Fig. 6A). ELF-EMF exposure increased
TE4 release from HEK293 cells in a time dependent manner (0.5 h:
2.3 ± 2.4%; 1 h: 25.2 ± 4.1%; 2 h: 7.9 ± 3.5%; 3 h: 6.1 ± 2.1%, Fig. 6D),
hich was consistent with the ELF-EMF inhibition of Cav3.2 chan-
els.ns ± S.E.M. from 45 cells. *P < 0.05 compared to non-EMF control. (D) Exposure to
av3.3 currents.
3.4. ELF-EMF exposure inhibits Cav3.1 and Cav3.3 channels via
LTE4
The above results demonstrated that ELF-EMF exposure
inhibited Cav3.2 channels via AA/LTE4 signaling pathway. We
next tested whether ELF-EMF (50 Hz, 0.2 mT)  exposure has simi-
lar inhibitory effects on Cav3.1/3.3 channels in HEK293 cells. As
shown in Fig. 7, 1 h ELF-EMF (0.2 mT)  exposure inhibited Cav3.1/3.3
channels signiﬁcantly (percent inhibition, Cav3.1: 21 ± 5.4%, n = 48;
Cav3.3: 17.6 ± 7.4%, n = 45; P < 0.05, compared to control, Fig. 7A and
B). Exposure to ELF-EMF did not alter the steady-state activation
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Fig. 8. Exogenous LTE4 mimics the ELF-EMF inhibition of Cav3.1 channels. (A) Sample current traces show the effect of the extracellular applying of 1 M LTE4 on Cav3.1
channels expressed in HEK293 cells (top left). The time course of the Cav3.1 current inhibition by 1 M LTE4 (bottom left). Statistical analysis of the effects of 1 M LTE4
on Cav3.1 channels (right). *P < 0.05 compared to control. (B) 1 M LTE4 did not change the steady-state activation curve of Cav3.1 currents (right); Sample current traces
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nd inactivation kinetics of Cav3.1 channels (activation, control:
1/2 = −46.3 ± 0.6; EMF: V1/2 = −47.3 ± 0.3; n = 18, P > 0.05; inacti-
ation, control: V1/2 = −68.2 ± 0.4; EMF: V1/2 = −68.7 ± 0.3; n = 18,
 > 0.05, Fig. 7B). Exposure to ELF-EMF also did not change the
teady-state activation and inactivation properties of Cav3.3 chan-
els (activation, control: V1/2 = −35.4 ± 0.2; EMF: V1/2 = −34.6 ± 0.3;
 = 17, P > 0.05; inactivation, control: V1/2 = −67.1 ± 0.2; EMF:
1/2 = −66.4 ± 0.3; n = 17, P > 0.05, Fig. 7D). We  then tested whether
xogenous LTE4 could mimic  the ELF-EMF inhibitory effects on
av3.1/3.3 channels.
Exogenous LTE4 inhibited Cav3.1 channels (32.5 ± 2%, n = 7,
 < 0.05, compared to control Fig. 8A) and did not alter the
teady-state activation (control: V1/2 = −48.1 ± 0.2 mV,  n = 7; LTE4:
1/2 = −48.8 ± 0.1 mV,  n = 7; P > 0.05, Fig. 8B) and inactivation (con-
rol: V1/2 = −72.2 ± 0.1 mV,  n = 7; LTE4: V1/2 = −72.1 ± 0.1 mV, n = 7;
 > 0.05, Fig. 8C) of Cav3.1 currents. LTE4 inhibited Cav3.3 chan-
els signiﬁcantly (34.3 ± 6.6%, n = 7, P < 0.05, compared to control,
ig. 9A), and did not change the steady-state activation (con-
rol: V1/2 = −35.8 ± 0.2 mV,  n = 7; LTE4: V1/2 = −34 ± 0.2 mV,  n = 7,
 > 0.05, Fig. 9B) and inactivation (control: V1/2 = −67.4 ± 0.3 mV,vation curve of Cav3.1 currents (right); Sample current traces with/without LTE4
n = 7; LTE4: V1/2 = −66.5 ± 0.3 mV,  n = 7, P > 0.05, Fig. 9C) kinetics of
Cav3.3 currents. The above data suggested that ELF-EMF exposure
inhibited Cav3.1, Cav3.2 and Cav3.3 channels in a similar way.
3.5. ELF-EMF exposure inhibits native T-type calcium channels in
mouse cortical neurons via LTE4
The primary cultured cortical neurons were used to test whether
ELF-EMF exposure inhibits native T-type channel currents via LTE4
pathway. The native T-type calcium channel currents in cortical
neurons were elicited by a 40-ms depolarizing pulse to −40 mV
from a holding potential of −90 mV at 10 s intervals. In order to
avoid any contribution of HVA currents, the 100 M Ni2+ was used
to conﬁrm the T-type Ca2+ currents. Ni+-sensitive Ca2+ currents
(Icontrol − INi2+ ) were used to calculate the ELF-EMF effect on T-type
channels. As shown in Fig. 10A, one hour exposure to ELF-EMF
(50 Hz, 0.2 mT)  inhibits Ni2+ sensitive T-type Ca2+ currents sig-
niﬁcantly in mouse cortical neurons. Bestatin, which blocks the
conversion from LTD4 to LTE4, abrogated the ELF-EMF inhibition
of T-type Ca2+ currents (EMF: 25.2 ± 1.6%, n = 35; EMF  + bestatin:
56 Y. Cui et al. / Cell Calcium 55 (2014) 48–58
Fig. 9. Exogenous LTE4 mimics the ELF-EMF inhibitory effect on Cav3.3 channels. (A) Representative current traces show the inhibitory effect of exogenous LTE4 on Cav3.3
channels expressed in HEK293 cells (top left). The time course of the Cav3.3 current inhibition by 1 M LTE4 (bottom left). Statistical analysis of the effect of 1 M LTE4
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.1 ± 5.9%, n = 32, P < 0.05, Fig. 10B). Exogenous LTE4 inhibited
ative T-type channel currents by 46.4 ± 5.9% (n = 5, Fig. 10C and
). The data above suggested that ELF-EMF inhibits native T-type
hannel currents in cortical neurons via LTE4 pathway.
. Discussion
In present study, we reports that exposure to ELF-EMF (50 Hz,
.2 mT)  inhibited cloned T-type calcium channels expressed in
EK293 cells via AA/LTE4 signaling pathway. Among T-type chan-
els, ELF-EMF preferentially inhibits Cav3.2 channels (Figs. 1 and 7).
orrespondingly, LTE4 has a greater inhibitory effect on Cav3.2
hannels than Cav3.1 and Cav3.3 channels (Figs. 6A, 8A and 9A).
It has been well documented that increased L-type channel
ctivity is involved in various ELF-EMF induced biological effects.
urprisingly, we ﬁnd that ELF-EMF exposure inhibits T-type cal-
ium channels. In agree with the previous report [26], exposure
o ELF-EMF (50 Hz) increases AA level in HEK293 cell. Exoge-
ous AA directly inhibits T-type calcium channels via shifting
nactivation curve to more negative potential [27,35,36]. Blocking
LF-EMF induced AA increase abrogated the ELF-EMF inhibition
f Cav3.2 channels (Fig. 3). However, ELF-EMF did not change thehe steady-state activation curve of Cav3.3 currents (right); Sample current traces
vation curve of Cav3.3 currents (right); Sample current traces with/without LTE4
steady-state inactivation kinetics of T-type channels (Fig. 2), and
NDGA, which blocks LOX pathway of AA, completely diminished
the ELF-EMF inhibition of Cav3.2 channels (Fig. 4). These data sug-
gest that ELF-EMF inhibition of T-type calcium channels is mediated
by metabolites of AA instead of AA direct effect.
Through LOX pathway, AA is ﬁnally converted to the cys-
teinyl leukotrienes (cys-LTs) including LTC4, LTD4 and LTE4.
So far, There are only two  cysteinyl leukotriene receptors
(CysLT1 and CysLT2) identiﬁed, which have high afﬁnity for
LTC4 and LTD4 binding, but have little afﬁnity for LTE4
[33,34]. A number of studies show that LTE4 regulate vari-
ous biological functions independent of CysLT1/CysLT2 receptors,
indicating the existence of unknown cysteinyl leukotriene recep-
tor/receptors for LTE4 [37–40]. Our results show that the
CysLT1/CysLT2 receptor inhibitor BAY9773 did not change the
ELF-EMF inhibitory effect on Cav3.2 channels (Fig. 5A), and that
blocking the conversion of LTD4 to LTE4 abrogated the ELF-EMF
inhibition of Cav3.2 channels (Fig. 5B). The data suggest that ELF-
EMF  inhibition of Cav3.2 channels is mediated by LTE4, but not via
classic CysLT1/CysLT2 receptors. The mechanism of LTE4 inhibition
of T-type calcium channels need to be investigated further. Cys-LTs
are highly potent mediators of inﬂammation, and play a key role in
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Fig. 10. ELF-EMF exposure inhibits native T-type calcium channels in mouse cortical neurons via LTE4. (A) Representative current traces show the native Ni2+ sensitive
T-type Ca2+ currents in mouse cortical neurons (top). The native T-type Ca2+ currents were elicited by a 40-ms depolarizing pulse to −40 mV from a holding potential of
−90  mV.  Sample current traces shown ELF-EMF inhibition of T-type Ca2+ currents in mouse cortical neurons (bottom). (B) Bestatin abrogated the ELF-EMF inhibition of T-type
Ca2+ currents in cortical neurons. Bar graph plots of means ± S.E.M. of normalized T-type Ca2+ currents. *P < 0.05 compared to non-EMF control. #P < 0.05 compared to the
EMF-exposed group without bestatin. (C) Representative current traces show the inhibitory effect of exogenous LTE4 on native T-type calcium channels in mouse cortical
neurons (top). The time course of T-type Ca2+ current inhibition by 1 M LTE4 (bottom). (D) Statistical analysis of the effect of 1 M LTE4 on T-type Ca2+ current. *P < 0.05
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sthma [41,42]. Urinary LTE4 has been used as a predictor of risk for
sthma in clinical study [43]. Exposure to ELF-EMF increases LTE4
ever (Fig. 6D), which may  provide a possible molecular explanation
or the previous epidemiological report that EMF  exposure could
e a risk factor for asthma [44]. The ELF-EMF induced increases
f both AA and LTE4 are time dependent, reaching maximum lev-
ls at about 1 h and disappeared after 2 h (Figs. 3A and 6D). That
ay  explain the biphasic inhibition of ELF-EMF exposure on T-type
hannel currents (Fig. 1).
The primary cultured mouse cortical neurons were used to
est whether ELF-EMF exposure inhibits native T-type channel
urrents. Mouse cortical neurons express both HVA and LVA cal-
ium channels. We  used low depolarization voltage (−40 mV)  to
void activation of HVA calcium channels, and used Ni2+ to further
onﬁrm that the recorded Ca2+ currents were form LVA channels
Fig. 10A). Our data show that 1 h ELF-EMF (50 Hz, 0.2 mT)  exposure
nhibits native T-type channel currents in mouse cortical neurons
ia LTE4 pathway.
In conclusion, our results provide the ﬁrst evidence that expo-ure to ELF-EMF increases LTE4 release, and that ELF-EMF exposure
nhibits cloned human T-type calcium channels expressed in
EK293 cells and native T-type channel currents in mouse cortical
eurons via AA/LTE4 signaling pathway.Conﬂict of interest
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